BCL11B and early-onset autosomal dominant Alzheimer disease: In addition, BCL11B has been previously shown to be critical for neurodevelopmental transcription with implications in multiple diseases of the central nervous system such as Huntington’s disease and Alzheimer’s disease [50–52].